Healius Ltd (ASX: HLS) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

Healius Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $838.68 million
P/E Ratio 55.56
Dividend Yield 0.00%
Shares Outstanding 726.13 million
Earnings per share -0.964
Dividend per share 0.12
Year To Date Return 12.41%
Earnings Yield 1.80%
Franking 100%
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

Healius Ltd (ASX: HLS)
Latest News

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an unhappy Thursday for ASX investors.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Core Lithium, Healius, Neuren, and Reject Shop shares are storming higher today

These shares are avoiding the market weakness on Thursday. But why?

Read more »

Happy man holding Australian dollar notes, representing dividends.
Healthcare Shares

This ASX 200 stock is rocketing 17% after announcing a $300m special dividend

A huge dividend is expected to be paid to investors in the near future.

Read more »

Three people jumping cheerfully in clear sunny weather.
Share Gainers

3 ASX 200 stocks rocketing higher this week even as the market dives

These three ASX 200 stocks are shrugging off the wider market sell-off this week to leap higher.

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a very woeful Wednesday indeed for investors today.

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

The market sent ASX investors back to earth this Tuesday.

Read more »

Man on a laptop thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors just endured another woeful Wednesday session.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a spectacular end to the trading week for the ASX today.

Read more »

Silhouettes of nine people climbing a steep mountain to the top at sunset, and helping each other along the way.
Share Gainers

Here are the top 10 ASX 200 shares today

The markets endured a rough start to the week this Monday.

Read more »

A woman smiles as she sits on the bus using her phone and listening to music through headphones.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a slow start to the week for ASX shares this Monday.

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors were pulled back down to earth this Tuesday.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Frequently Asked Questions

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
07 Sep 2022 $0.0600 100.00% Final 21 Sep 2022
24 Mar 2022 $0.1000 100.00% Interim 05 Apr 2022
13 Sep 2021 $0.0675 100.00% Final 08 Oct 2021
25 Mar 2021 $0.0650 100.00% Interim 15 Apr 2021
26 Mar 2020 $0.0260 100.00% Interim 15 Oct 2020
29 Aug 2019 $0.0340 100.00% Final 27 Sep 2019
15 Mar 2019 $0.0380 100.00% Interim 26 Mar 2019
27 Aug 2018 $0.0550 100.00% Final 17 Sep 2018
16 Mar 2018 $0.0510 100.00% Interim 27 Mar 2018
31 Aug 2017 $0.0000 100.00% Final 18 Sep 2017
17 Mar 2017 $0.0480 100.00% Interim 28 Mar 2017
01 Sep 2016 $0.0640 100.00% Final 19 Sep 2016
18 Mar 2016 $0.0560 50.00% Interim 29 Mar 2016
26 Aug 2015 $0.1100 50.00% Final 14 Sep 2015
18 Mar 2015 $0.0900 100.00% Interim 07 Apr 2015
27 Aug 2014 $0.1100 100.00% Final 15 Sep 2014
17 Mar 2014 $0.0900 100.00% Interim 07 Apr 2014
16 Sep 2013 $0.1100 100.00% Final 08 Oct 2013
18 Mar 2013 $0.0650 100.00% Interim 08 Apr 2013
17 Sep 2012 $0.0600 100.00% Final 08 Oct 2012
26 Mar 2012 $0.0500 100.00% Interim 16 Apr 2012
19 Sep 2011 $0.0500 100.00% Final 10 Oct 2011
21 Mar 2011 $0.0300 100.00% Interim 11 Apr 2011
20 Sep 2010 $0.1000 100.00% Final 11 Oct 2010
05 Mar 2010 $0.1500 100.00% Interim 29 Mar 2010
07 Sep 2009 $0.0700 100.00% Final 28 Sep 2009
16 Feb 2009 $0.0700 100.00% Interim 09 Mar 2009
08 Sep 2008 $0.0500 100.00% Final 09 Oct 2008
22 Feb 2008 $0.2200 100.00% Interim 17 Mar 2008
31 Aug 2007 $0.2400 100.00% Final 24 Sep 2007
09 Mar 2007 $0.2100 100.00% Interim 02 Apr 2007
09 Oct 2006 $0.0800 100.00% Special Cash 30 Oct 2006
04 Sep 2006 $0.2200 100.00% Final 25 Sep 2006
20 Feb 2006 $0.2000 100.00% Interim 13 Mar 2006
22 Aug 2005 $0.1300 100.00% Final 12 Sep 2005
08 Apr 2004 $0.0750 100.00% Interim 03 May 2004

HLS ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Healius Ltd

Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.

The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres. 

The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics. 

HLS Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
08 May 2025 $1.54 $-0.06 -3.75% 8,896,674 $1.62 $1.62 $1.54
07 May 2025 $1.60 $0.02 1.27% 8,037,573 $1.58 $1.61 $1.55
06 May 2025 $1.58 $0.02 1.28% 8,442,083 $1.60 $1.64 $1.57
05 May 2025 $1.57 $0.06 3.99% 4,004,985 $1.54 $1.60 $1.52
02 May 2025 $1.51 $-0.01 -0.66% 1,589,925 $1.53 $1.55 $1.50
01 May 2025 $1.52 $0.06 4.12% 2,536,644 $1.47 $1.54 $1.47
30 Apr 2025 $1.46 $0.02 1.39% 1,803,202 $1.45 $1.47 $1.44
29 Apr 2025 $1.44 $0.04 2.86% 2,749,284 $1.40 $1.47 $1.40
28 Apr 2025 $1.40 $0.01 0.72% 2,364,303 $1.40 $1.43 $1.39
24 Apr 2025 $1.39 $0.02 1.47% 2,315,896 $1.37 $1.42 $1.36
23 Apr 2025 $1.37 $0.03 2.25% 2,995,614 $1.37 $1.38 $1.35
22 Apr 2025 $1.34 $-0.04 -2.92% 2,979,756 $1.36 $1.39 $1.33
17 Apr 2025 $1.37 $0.03 2.23% 1,889,509 $1.35 $1.38 $1.34
16 Apr 2025 $1.35 $-0.02 -1.47% 1,864,377 $1.35 $1.38 $1.34
15 Apr 2025 $1.36 $-0.02 -1.45% 1,418,842 $1.38 $1.39 $1.35
14 Apr 2025 $1.38 $-0.02 -1.43% 967,886 $1.41 $1.43 $1.38
11 Apr 2025 $1.40 $-0.04 -2.78% 2,188,144 $1.43 $1.43 $1.38
10 Apr 2025 $1.44 $0.04 2.86% 3,556,519 $1.46 $1.49 $1.40
09 Apr 2025 $1.40 $0.06 4.48% 4,670,599 $1.32 $1.41 $1.30

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
21 Nov 2024 Michael Stanford Buy 40,000 $53,200
On-market trade.
21 Nov 2024 Sally Evans Buy 30,418 $39,847
On-market trade.
20 Nov 2024 Paul Anderson Buy 37,837 $48,052
On-market trade.
20 Nov 2024 Kathryn (Kate) McKenzie Buy 40,000 $52,000
On-market trade.
27 Aug 2024 Sally Evans Exercise 16,450 $25,000
Conversion of securities. VWAP
27 Aug 2024 Sally Evans Buy 16,450 $25,000
Conversion of securities. VWAP
27 Aug 2024 Charlie Taylor Exercise 16,450 $25,000
Conversion of securities. VWAP
27 Aug 2024 Charlie Taylor Buy 16,450 $25,000
Conversion of securities. VWAP
21 May 2024 Kathryn (Kate) McKenzie Transfer 2,559 $3,224
Off-market transfer.
21 May 2024 Kathryn (Kate) McKenzie Transfer 2,559 $3,224
Off-market transfer.
14 May 2024 John Mattick Transfer 15,093 $20,224
As advised by the company. a transfer of NED Restricted Shares to the custodian
under the Healius NED Share Plan.
14 May 2024 John Mattick Transfer 15,093 $20,224
As advised by the company. Transfer of NED Restricted shares to the custodian under the
Healius NED Share Plan
14 May 2024 Gordon Davis Transfer 40,214 $53,886
As advised by the company. Transfer of NED Restricted shares to the custodian
under the Healius NED Share Plan.
14 May 2024 Gordon Davis Transfer 40,214 $53,886
As advised by the company. Transfer of NED Restricted shares to the custodian
under the Healius NED Share Plan.
14 May 2024 Sally Evans Transfer 51,332 $68,784
As advised by the company. Transfer of NED Restricted shares to the custodian under the
Healius NED Share Plan.
14 May 2024 Sally Evans Transfer 51,332 $68,784
As advised by the company. Transfer of NED Restricted shares to the custodian under the
Healius NED Share Plan.
14 May 2024 Charlie Taylor Transfer 16,450 $22,043
As advised by the company. Transfer of NED Restricted shares to the custodian under the
Healius NED Share Plan.
14 May 2024 Charlie Taylor Transfer 16,450 $22,043
As advised by the company. Transfer of NED Restricted shares to the custodian under the
Healius NED Share Plan.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Michael Philip Stanford Non-Executive Director Sep 2023
Dr Stanford is a member of the People & Governance Committees. Michael has over 20 years of experience as a Chief Executive Officer and Managing Director of multi-campus and multi-service health care organisations with national and international areas of operation, including St John of God Health Care, Australian Hospital Care Ltd, North-Western Health, North-Eastern Health Care Network and Austin & Repatriation Medical Centre.
Professor John Mattick Non-Executive Director Mar 2022
Professor Mattick is a member of the Risk Management Committees. John is a Professor in the School of Biotechnology and Biomolecular Science at UNSW Sydney. He was Chief Executive of Genomics England and Executive Director of the Garvan Institute of Medical Research. He was a member of the Australian Health Ethics Committee of the National Health & Medical Research Council, an advisor to the Australian Law Reform Commission's Inquiry into the Protection of Human Genetic Information and Gene Patenting & Human Health.
Mr Paul Anderson Chief Executive OfficerManaging Director Mar 2024
Mr Anderson has background in industries facing disruption. He was previously Chief Executive Officer of Network Ten and more recently, Executive Vice President at Viacom CBS Networks Australia & NZ. He also spent more than a decade working abroad at CLS Holdings plc in London and KPMG in New Zealand.
Ms Kathryn (Kate) Mary McKenzie Non-Executive ChairmanNon-Executive Director Feb 2021
Ms McKenzie is Chair of the Risk Committee and a member of the People & Governance Committee. Kate has corporate governance experience and has held several executive roles, including CEO of Chorus Limited (NZ) and COO of Telstra. She also held the roles of CEO of the NSW Department of Commerce and CEO of WorkCover. She is on the Board of Stockland and Chair of nbnco.
Ms Sally Evans Non-Executive Director Aug 2018
Ms Evans is Chair of the People & Governance Committee and a member of the Risk Management Committee. Sally has over 30 years of experience in private, government and social enterprise sectors and has worked in Australia, New Zealand, the United Kingdom, and Hong Kong with responsibilities across the broader Asia Pacific region. She is a board member of Allianz Australia Life, Oceania Healthcare (NZ) and Ingenia Communities.
Ms Katherine (Kathy) Ostin Non-Executive Director Dec 2024
Ms Ostin was an Audit, Assurance and Risk Consulting Partner at KPMG from 2005 to 2017 and has experience in the aged care and healthcare sectors, having established and led KPMGs Health, Aging and Human Services audit practice from 2006 to 2018. During her 24 years with KPMG, Ms Ostin worked in Australia, the US, Asia and UK. Ms Ostins other current ASX board and audit chair roles include for 3P Learning Limited (ASX:3PL) as a Non-Executive Director and Chair of Audit & Risk Committee, Capral Limited (ASX:CAP) as a Non Executive Director and Chair of Audit & Risk Committee, dusk Group Limited (ASX:DSK) as a Non Executive Director and Chair of Audit & Risk Committee, Elanor Investors Group (ASX:ENN) and Elanor Commercial Property Fund (ASX:ECF) as a Non-Executive Director and Next Science Limited (ASX:NXS) as a Non-Executive Director and Chair of Audit & Risk Committee.
Mr Charlie Taylor Non-Executive Director Mar 2023
Mr Taylor has over 30 years of experience in international advisory firms, including as Senior Partner at McKinsey where he led the Health and Public Sector practices. He has advised many of Australia's private and public sector healthcare organisations and initiated multi-year research efforts on healthcare, Covid response, productivity, and innovation. He is also a member of People & Governance Committee.
Mr Neil Vinson Non-Executive Director Mar 2025
--
Mrs Mary Weaver Company Secretary Mar 2023
-
Mr Stephen Humphries Company Secretary Mar 2023
-
Steve Humphries Chief Financial Officer
-
Mary Weaver Company Secretary
-
Stephen Humphries Company Secretary
-
Prasad Arav Group Executive Digital & Technology and Strategy
-
Phil Lucas Group Executive Lumus Imaging
-
Paula Bayliss Group Executive People & Culture
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 211,636,287 29.15%
Citicorp Nominees Pty Limited 209,962,638 28.92%
J P Morgan Nominees Australia Pty Limited 127,569,782 17.57%
Argo Investments Limited 22,874,452 3.15%
BNP Paribas Noms Pty Ltd 19,666,305 2.71%
BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 12,096,389 1.67%
HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 5,855,473 0.81%
Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 4,335,651 0.60%
National Nominees Limited 3,718,898 0.51%
First Samuel Ltd Acn 086243567 <Anf Its Mda Clients A/C> 3,469,215 0.48%
Rinrim Pty Ltd 2,497,161 0.34%
HSBC Custody Nominees (Australia) Limited i 2,037,242 0.28%
BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 939,397 0.12%
HSBC Custody Nominees (Australia) Limited <Gsco Customers A/C> 838,693 0.12%
Netwealth Investments Limited <Wrap Services A/C> 731,765 0.10%
Joromada Pty Ltd 660,000 0.09%
Buttonwood Nominees Pty Ltd 658,941 0.09%
Sep Super Pty Ltd <Sep Super Fund A/C> 637,236 0.09%
Mr Gregory Anthony Thomas Bateman 636,213 0.08%
Ioof Investment Services Limited <Ips Superfund A/C> 609,635 0.08%

Profile

since

Note